Behind the markets
Behind the markets

Daily Trades

February 29, 2024 – Cerevel Therapeutics (SYM: CERE) & Updates

Back in the 90’s, Wall Street started putting pressure on Big Pharma to get better returns on their R&D spending.
Learn More

February 21, 2024 – Iovance (SYM: IOVA)

Judging by all the emails we got over the weekend, most of you know Iovance Biotheutics (SYM: IOVA) won FDA approval for lifileucel.
Learn More

January 11, 2024 – Shockwave (SYM: SWAV) & Updates

Rumors of a takeover have surrounded Shockwave for years. This cardiovascular device maker would make a great fit for Johnson & Johnson, Medtronic or Boston Scientific.
Learn More

November 22, 2023 – Happy Thanksgiving!

I’m also thankful that I get to share some good news with you today regarding Iovance Biotherapeutics (SYM: IOVA).
Learn More

September 21, 2023 – Iovance Biotherapeutics (SYM: IOVA)

I’ve been touting Iovance (SYM: IOVA) for so long, I may have to fall on my sword Japanese-style if it doesn’t work out.
Learn More

July 10, 2023 – Iovance (SYM: IOVA)

Iovance (SYM: IOVA) jumped 20% today after announcing news that its lung cancer candidate LN-145 could be acceptable for a potential accelerated approval.
Learn More

June 1, 2023 – (SIMO, TSEM, WDC, ATVI, IOVA, TECK)

We have a strong group of stocks, so I want to take today to highlight some of the best opportunities I haven’t talked about recently (and update others).
Learn More

May 25, 2023 – Iovance Biotherapeutics (SYM: IOVA)

A lot of newer members have written in to ask about Iovance Biotherapeutics (SYM: IOVA).
Learn More

April 27, 2023 – Iovance (SYM: IOVA), Activision (SYM: ATVI)

Two things I want to discuss this week…
Learn More

January 26, 2023 – Iovance (SYM: IOVA)

We haven’t talked about Iovance Bio (SYM: IOVA) in a while. I figured I’d use this issue to update you on it, since there were slim pickins’ out there this week anyway.
Learn More

deal of the month

best growth stocks

Alliance

Bundle package – lifetime subscriptions for all products

Get Deal

Categories

Behind the Markets

778 subscribers

Behind the Markets: independent research for independent investors.

Behind the Markets
In this video, we'll explore the recent turbulence affecting small-cap stocks, particularly in the biotech sector. Dylan will share essential strategies to maintain your composure amidst market chaos. Drawing from his early experiences on Wall Street and advice from mentors, Dylan explains why it's crucial not to "pee on the rug at the first sound of thunder." You'll learn about the importance of investing in solid businesses and not panicking at the first sign of trouble. If you're feeling uncertain about your investments, this video provides practical advice and encouragement. Please hit like, subscribe, and share if you find these insights helpful. Remember to stay calm and resilient, because steady wins the race! ✅ SUBSCRIBE TO THE CHANNEL 👇🏼👇🏼 https://www.youtube.com/channel/UCczJ4YRRQLl6KrH06iapaRw?sub_confirmation=1 ✅ VISIT OUR WEBSITE 👇🏼👇🏼 https://behindthemarkets.com/
YouTube Video VVVjeko0WVJSUUxsNktySDA2aWFwYVJ3LkVoQ09KWVBnT3lB

Handling Market Dips: A Little Advice from a Wall Street Insider

In this video, we dive deep into the current geopolitical tensions involving the United States, Israel, and Iran. Our video dissects the possible repercussions of an escalated conflict in the Middle East and why it might be a catastrophic mistake for the U.S. to engage in a war that doesn't align with national security priorities. We explore the historical context of the shadow war between Israel and Iran, and the implications of Israel's recent actions that indirectly involved Iranian territory. This includes the strike on an Iranian consulate, a move that escalated tensions but was met with a measured response from Iran, indicating a possible avoidance of further escalation. Additionally, the video sheds light on the broader implications for U.S. foreign policy, emphasizing the importance of focusing on domestic priorities and strategic international investments, like supporting Ukraine and monitoring developments in Taiwan due to its significance in semiconductor production. Join us as we unravel the complexities of these interactions, the potential mistakes in escalating conflicts, and the strategic choices the U.S. might consider to maintain global stability while securing its interests. Your thoughts and opinions are invaluable—share them in the comments below and let's discuss what the future should hold for U.S. involvement in Middle East affairs. ✅ SUBSCRIBE TO THE CHANNEL 👇🏼👇🏼 https://www.youtube.com/channel/UCczJ4YRRQLl6KrH06iapaRw?sub_confirmation=1 ✅ VISIT OUR WEBSITE 👇🏼👇🏼 https://behindthemarkets.com/
YouTube Video VVVjeko0WVJSUUxsNktySDA2aWFwYVJ3LkxROHJOTHBIX2t3

Israel vs. Iran: The Mistake That Could Drag the U.S. into War

In today’s video, we delve deep into the often overlooked geopolitical risks associated with our global dependency on artificial intelligence (AI) technologies. While AI continues to shape the future in extraordinary ways, there's a critical factor that might disrupt this progress: the semiconductor supply chain. Most of the world's advanced semiconductors, crucial for everything from mobile phones to AI systems, are manufactured in Taiwan by Taiwan Semiconductor Manufacturing Company (TSMC). However, with rising tensions in the region and China's increasing assertiveness towards Taiwan, the stability of this supply chain is under significant threat. In the past month alone, major companies like Samsung, TSMC, and Intel have received substantial funding from the U.S. government, aimed at boosting semiconductor production within the United States. This strategic move highlights a growing awareness of the risks posed by potential conflicts in Taiwan—a scenario that could have profound impacts on global technology supply chains. Join us as we analyze these complex dynamics, including the strategic moves by global and national powers to secure semiconductor production, and discuss the potential implications on AI development and broader technological advancements. We'll also offer insights into the actions companies and governments are taking to mitigate these risks. Don't forget to like, subscribe, and click the bell icon to stay updated on our latest content, where we continue to uncover the critical intersections between technology and geopolitics. Share your thoughts in the comments below: How do you think these developments will affect the future of technology and global stability? ✅ SUBSCRIBE TO THE CHANNEL 👇🏼👇🏼 https://www.youtube.com/channel/UCczJ4YRRQLl6KrH06iapaRw?sub_confirmation=1 ✅ VISIT OUR WEBSITE 👇🏼👇🏼 https://behindthemarkets.com/
YouTube Video VVVjeko0WVJSUUxsNktySDA2aWFwYVJ3LkxzZ0ZxaUhtYVpJ

The Looming Threat to Nvidia and AI

Load More... Subscribe

Recent posts

Chart of Day: Curaleaf Holdings (CURLF) – 4/19

Pay Close Attention to Mining Stocks with Bitcoin Halving

Crisis is Opportunity for These Two Tech Giants – 4/19

The Top Benefits of Investing in an Exchange Traded Funds

Tags

Connect with Us

Icon-facebook Icon-btmshare_tw

February 29, 2024 – Cerevel Therapeutics (SYM: CERE) & Updates

Back in the 90’s, Wall Street started putting pressure on Big Pharma to get better returns on their R&D spending.
Learn More

February 21, 2024 – Iovance (SYM: IOVA)

Judging by all the emails we got over the weekend, most of you know Iovance Biotheutics (SYM: IOVA) won FDA approval for lifileucel.
Learn More

January 11, 2024 – Shockwave (SYM: SWAV) & Updates

Rumors of a takeover have surrounded Shockwave for years. This cardiovascular device maker would make a great fit for Johnson & Johnson, Medtronic or Boston Scientific.
Learn More

November 22, 2023 – Happy Thanksgiving!

I’m also thankful that I get to share some good news with you today regarding Iovance Biotherapeutics (SYM: IOVA).
Learn More

September 21, 2023 – Iovance Biotherapeutics (SYM: IOVA)

I’ve been touting Iovance (SYM: IOVA) for so long, I may have to fall on my sword Japanese-style if it doesn’t work out.
Learn More

July 10, 2023 – Iovance (SYM: IOVA)

Iovance (SYM: IOVA) jumped 20% today after announcing news that its lung cancer candidate LN-145 could be acceptable for a potential accelerated approval.
Learn More

June 1, 2023 – (SIMO, TSEM, WDC, ATVI, IOVA, TECK)

We have a strong group of stocks, so I want to take today to highlight some of the best opportunities I haven’t talked about recently (and update others).
Learn More

May 25, 2023 – Iovance Biotherapeutics (SYM: IOVA)

A lot of newer members have written in to ask about Iovance Biotherapeutics (SYM: IOVA).
Learn More

April 27, 2023 – Iovance (SYM: IOVA), Activision (SYM: ATVI)

Two things I want to discuss this week…
Learn More

January 26, 2023 – Iovance (SYM: IOVA)

We haven’t talked about Iovance Bio (SYM: IOVA) in a while. I figured I’d use this issue to update you on it, since there were slim pickins’ out there this week anyway.
Learn More

Get FREE Daily Stock Tips

Join and receive market insider stock picks, trade alerts and unique investing insights
This field is for validation purposes and should be left unchanged.
By clicking the "Subscribe" button you are accepting our Terms of Use and Privacy Policy.
Behind the markets

Company

Explore

CUSTOMER SERVICE

  • We’re here to help.
    Contact Us:
    Mon – Fri | 10 AM – 7 PM EST
  • 1-800-851-1965

© 2024 Behind the Markets, LLC. All rights reserved.

Join Waitlist

We’re sorry, but due to the popularity of our services, we have reached our max number of subscribers and are not currently accepting more. If spots become available, we will be sure to contact you. Please join the waitlist below.
Thank You!

"*" indicates required fields

Name*
This field is for validation purposes and should be left unchanged.